StockData
Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc. (RYTM) stock

RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)

Close on Nov 17, 2026Market cap $8.03BP/E –Yield –

Rhythm Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Rhythm Pharmaceuticals

Rhythm Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Rhythm Pharmaceuticals figures

See a number that looks wrong?